Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Anticipates “Major Consolidation” In Generic Industry In 2005

Executive Summary

Teva is preparing for another round of consolidation within the generic industry during 2005, North America CEO George Barrett said Jan. 13 at the J.P. Morgan health care conference in San Francisco
Advertisement

Related Content

Teva/Ivax Merger Will Create Significant Pricing Flexibility In Generics
Teva/Ivax Merger Will Create Significant Pricing Flexibility In Generics
Novartis Seeks To Be Generics “Powerhouse” With Eon, Hexal Acquisitions
Generic Industry Faces Downturn, Sandoz Says; MMA Changes Hurt
Cardinal Plans Generic Cardiolite, Other Moves To Expand Generic Presence
Generic Price War Remains Strong; Intensity Is Product Specific, Firms Say
Generic Price War Remains Strong; Intensity Is Product Specific, Firms Say
Sandoz Gets New Leader: Is Restructuring Next For Novartis’ Generics Unit?
Brand Firm In-House Generics Unlikely To Grab Large Market Share – Analyst
Mylan Takes “Authorized” Generics Fight To Congress, FTC, Courts

Topics

Advertisement
UsernamePublicRestriction

Register

PS045261

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel